Business Context and Reporting Period
IM Cannabis Corp., an Israeli foreign private issuer, filed Form 6-K on August 14, 2023. The filing covers the six months ended June 30, 2023 and includes interim consolidated financial statements, management’s discussion and analysis, a news release, quarterly listing statement, and management certifications.
Financial Metrics
The provided filing text is limited to the Form 6-K cover page and exhibit index. It does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, assets, liabilities, or other financial metrics.
Material Changes Versus the Prior Comparable Period
The provided text does not describe material changes versus the prior comparable period. Comparative information may be included in the attached interim financial statements and management’s discussion and analysis, which are listed but not provided in the source text.
Guidance, Outlook, Risks, and Unusual Items
The provided text does not include guidance, outlook, management commentary, risk factors, contingencies, or unusual items. These matters may be addressed in Exhibits 99.1 and 99.3.
Important Facts to Verify
- Review Exhibit 99.2 for the interim consolidated financial statements for the six months ended June 30, 2023.
- Review Exhibit 99.3 for revenue trends, profitability, cash flow, liquidity, debt, operating results, risks, and management commentary.
- Review Exhibit 99.1 for reported business developments, guidance, and unusual items.
- Confirm the comparative-period figures and accounting presentation in the interim financial statements.
- Note that the Form 6-K was signed by CEO and Director Oren Shuster on August 14, 2023, with CFO and CEO certifications included as Exhibits 99.4 and 99.5.